JPMorgan Chase & Co’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $284K | Sell |
|
|||||
|
2025
Q1 | $558K | Sell |
|
|||||
|
2024
Q4 | $1.36M | Buy |
|
|||||
|
2024
Q3 | $383K | Sell |
|
|||||
|
2024
Q2 | $673K | Sell |
|
|||||
|
2024
Q1 | $695K | Sell |
|
|||||
|
2023
Q4 | $688K | Buy |
|
|||||
|
2023
Q3 | $267K | Sell |
|
|||||
|
2023
Q2 | $470K | Buy |
|
|||||
|
2023
Q1 | $428K | Buy |
|
|||||
|
2022
Q4 | $334K | Buy |
|
|||||
|
2022
Q3 | $253K | Buy |
|
|||||
|
2022
Q2 | $218K | Buy |
|
|||||
|
2022
Q1 | $215K | Sell |
|
|||||
|
2021
Q4 | $350K | Buy |
|
|||||
|
2021
Q3 | $282K | Sell |
|
|||||
|
2021
Q2 | $289K | Buy |
|
|||||
|
2021
Q1 | $259K | Sell |
|
|||||
|
2020
Q4 | $405K | Buy |
|
|||||
|
2020
Q3 | $272K | Buy |
|
|||||
|
2020
Q2 | $277K | Buy |
|
|||||
|
2020
Q1 | $207K | Sell |
|
|||||
|
2019
Q4 | $380K | Buy |
|
|||||
|
2019
Q3 | $362K | Sell |
|
|||||
|
2019
Q2 | $261K | Sell |
|
|||||
|
2019
Q1 | $723K | Buy |
|
|||||
|
2018
Q4 | $705K | Sell |
|
|||||
|
2018
Q3 | $2.68M | Buy |
|
|||||
|
2018
Q2 | $285K | Sell |
|
|||||
|
2018
Q1 | $1.08M | Sell |
|
|||||
|
2017
Q4 | $1.69M | Buy |
|
|||||
|
2017
Q3 | $982K | Buy |
|
|||||
|
2017
Q2 | $29K | Sell |
|
|||||
|
2017
Q1 | $1.5M | Sell |
|
|||||
|
2016
Q4 | $2.66M | Buy |
|
|||||
|
2016
Q3 | $551K | Buy |
|
|||||
|
2016
Q2 | $44K | Buy |
|
|||||
|
2016
Q1 | $10K | Hold |
|
|||||
|
2015
Q4 | $9K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $566K | Buy |
|